haloperidol has been researched along with Ache in 89 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is an open-label, parallel-group, randomized controlled trial to compare the efficacy and safety of dexmedetomidine and haloperidol for nocturnal hyperactive delirium in non-intubated patients at two HDUs of a tertiary hospital." | 9.69 | Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial). ( Harada, H; Ikeda, K; Kamei, J; Kato, T; Kitajima, N; Kuriyama, A; Maeda, J; Matsuyama, A; Minami, T; Mizota, T; Ohtsuru, S; Sakai, Y; Sato, Y; Takatani, Y; Ueno, K; Watanabe, H; Yamaji, K; Yamashita, Y, 2023) |
| "The use of very-low-dose methadone in conjunction with haloperidol in the acute-care setting resulted in improved pain control after conversion from typical opiates." | 7.81 | The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. ( Bruera, E; Buckley, JS; Buckley, NS; Salpeter, SR, 2015) |
| "The ketamine (ket) model reflects features of schizophrenia as well as secondary symptoms such as altered pain sensitivity." | 7.75 | Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia. ( Becker, A; Grecksch, G; Hiemke, C; Ladstaetter, E; Schmitt, U; Zernig, G, 2009) |
| "This study compared effects of the mu opioid receptor agonist morphine (an acknowledged analgesic), the dopamine receptor antagonist haloperidol (a non-analgesic sedative), the adenosine receptor antagonist caffeine (a non-analgesic stimulant) and the neurokinin-1 receptor antagonist CJ 11,974-01 (a candidate analgesic) on acetic acid-induced writhing (a traditional pain-stimulated behavior) and acetic acid-induced suppression of locomotor activity (a pain-depressed behavior) in male ICR mice." | 7.75 | Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. ( Adams, C; Bilsky, EJ; Cormier, J; Dunbar, C; Mercer, H; Negus, SS; Stevenson, GW, 2009) |
| "This is an open-label, parallel-group, randomized controlled trial to compare the efficacy and safety of dexmedetomidine and haloperidol for nocturnal hyperactive delirium in non-intubated patients at two HDUs of a tertiary hospital." | 5.69 | Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial). ( Harada, H; Ikeda, K; Kamei, J; Kato, T; Kitajima, N; Kuriyama, A; Maeda, J; Matsuyama, A; Minami, T; Mizota, T; Ohtsuru, S; Sakai, Y; Sato, Y; Takatani, Y; Ueno, K; Watanabe, H; Yamaji, K; Yamashita, Y, 2023) |
| "Based on the present data, adding haloperidol plus midazolam to morphine for pain management improved pain scores and lowered morphine consumption among opium-dependent patients." | 5.22 | Midazolam Plus Haloperidol as Adjuvant Analgesics to Morphine in Opium Dependent Patients: A Randomized Clinical Trial. ( Afzalimoghaddam, M; Edalatifard, M; Isavi, N; Karimialavijeh, E; Momeni, M; Nejati, A, 2016) |
| " Fentanyl, midazolam, and dexmedetomidine were the first choices of agents for analgesic, sedation, and delirium treatment." | 3.85 | A National Multicenter Survey on Management of Pain, Agitation, and Delirium in Intensive Care Units in China. ( Hu, B; Li, JG; Peng, ZY; Rao, X; Wang, J; Zhou, WH, 2017) |
| "The use of very-low-dose methadone in conjunction with haloperidol in the acute-care setting resulted in improved pain control after conversion from typical opiates." | 3.81 | The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. ( Bruera, E; Buckley, JS; Buckley, NS; Salpeter, SR, 2015) |
| "Morphine is co-administered with adjuvant drugs to treat pain, nausea, vomiting, dyspnoea and delirium in cancer patients." | 3.80 | Analgesic effects of morphine in combination with adjuvant drugs in rats. ( Kaminska, E; Leppert, W; Mikolajczak, P; Okulicz-Kozaryn, I; Szulc, M, 2014) |
| "Tramadol is often coadministered subcutaneously with adjuvants to treat pain, nausea/vomiting, dyspnea and delirium in cancer patients." | 3.79 | Analgesic effects of tramadol in combination with adjuvant drugs: an experimental study in rats. ( Kaminska, E; Leppert, W; Mikolajczak, P; Okulicz-Kozaryn, I, 2013) |
| "The ketamine (ket) model reflects features of schizophrenia as well as secondary symptoms such as altered pain sensitivity." | 3.75 | Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia. ( Becker, A; Grecksch, G; Hiemke, C; Ladstaetter, E; Schmitt, U; Zernig, G, 2009) |
| "We evaluated the effects of haloperidol and its metabolites on capsaicin-induced mechanical hypersensitivity (allodynia) and on nociceptive pain induced by punctate mechanical stimuli in mice." | 3.75 | Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors. ( Baeyens, JM; Cendán, CM; Cobos, EJ; Del Pozo, E; Entrena, JM; Nieto, FR, 2009) |
| "This study compared effects of the mu opioid receptor agonist morphine (an acknowledged analgesic), the dopamine receptor antagonist haloperidol (a non-analgesic sedative), the adenosine receptor antagonist caffeine (a non-analgesic stimulant) and the neurokinin-1 receptor antagonist CJ 11,974-01 (a candidate analgesic) on acetic acid-induced writhing (a traditional pain-stimulated behavior) and acetic acid-induced suppression of locomotor activity (a pain-depressed behavior) in male ICR mice." | 3.75 | Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. ( Adams, C; Bilsky, EJ; Cormier, J; Dunbar, C; Mercer, H; Negus, SS; Stevenson, GW, 2009) |
| "Formalin-induced pain is reduced in sigma-1 (sigma1) receptor knockout mice; therefore, we hypothesized that haloperidol and its metabolites I and II, which have affinity for sigma1 receptors, may modulate formalin-induced pain." | 3.73 | Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. ( Baeyens, JM; Cendán, CM; Portillo-Salido, E; Pujalte, JM, 2005) |
| " Peripherally administered beta-endorphin significantly elevated the pain threshold only in the iron-deficient rats." | 3.67 | The increased opiate action of beta-endorphin in iron-deficient rats: the possible involvement of dopamine. ( Yehuda, S; Youdim, MB, 1984) |
| "In the rat, elevating dopamine content in corpus striatum with electrical stimulation of substantia nigra or direct administration of apomorphine (50-200 micrograms) into the lateral cerebral ventricle or apomorphine (2-10 microgram) into the caudate-putamen complex decreased pain sensitivity (as shown by an increase in the latency to hind-paw lick in the hot plate test)." | 3.66 | Activation of striatal dopamine receptors induces pain inhibition in rats. ( Chandra, A; Lin, MT; Tsay, BL; Wu, JJ, 1981) |
| "Post-obturation pain is frustrating to both patients and dentists." | 2.80 | Incidence of post-obturation pain after single-visit versus multiple-visit non-surgical endodontic treatments. ( Chu, CH; Li, SK; Wong, AW; Zhang, C; Zhang, S; Zhu, X, 2015) |
| "As treatment approaches have advanced, more attention has been given to re-integrating patients into their psychosocial environments, rather than simply monitoring psychotic symptoms." | 2.71 | Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. ( Delbello, MP; Glick, I; Green, AI; Hamer, RM; Johnson, JL; Lieberman, JA; Patel, JK; Strakowski, SM; Tohen, M, 2005) |
| "Haloperidol has been found to be very efficient in controlling agitation with or without pain, nausea and/or vomiting of central origin, intestinal obstruction, and delirium." | 1.33 | Stability of tramadol and haloperidol for continuous subcutaneous infusion at home. ( Azuara, ML; Barcia, E; Martín, A; Negro, S; Sánchez, Y, 2005) |
| "At the time of peak hyperalgesia, WIN55,212-2 (1-30mg/kg) or vehicle was administered intraperitoneally and forelimb grip force was measured 0." | 1.32 | A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. ( Croft, DL; Hamamoto, DT; Kehl, LJ; Norsted, BD; Simone, DA; Wacnik, PW; Wilcox, GL, 2003) |
| "Vomiting was controlled in all patients, with the exception of three patients with upper abdomen obstruction who required nasogastric tube placement." | 1.28 | The management of inoperable gastrointestinal obstruction in terminal cancer patients. ( Caraceni, A; De Conno, F; Messina, L; Ripamonti, C; Spoldi, E; Ventafridda, V, 1990) |
| "Pretreatment with methysergide IT completely blocked gnawing produced by intrathecally injected serotonin but not that evoked by tail pinch." | 1.26 | Serotonin-induced gnawing in rats: comparison with tail pinch-induced gnawing. ( Kondzielski, MH; Larson, AA, 1982) |
| "Haloperidol was observed to be an effective analgesic, alone and in combination with opiates, in a patient with severe radiation fibrosis and necrosis." | 1.26 | Haloperidol analgesia. ( Cohen-Cole, SA; Daw, JL, 1981) |
| " A dosing strategy for the combbination of clomipramine and haloperidol is described." | 1.26 | [The treatment of chronic pain symptoms with psychotropic drugs (author's transl)]. ( Kocher, R, 1976) |
| " A clearcut dosage schedule for in- and out-patients using imipramine (Tofranil) or chlorimipramine (Anafranil) and haloperidol (Haldol) is established." | 1.26 | [The treatment of chronic pain with psychotropic drugs]. ( Kocher, R, 1978) |
| "Four approaches were used to alter transmission in monoamine pathways." | 1.25 | Monoaminergic mechanisms of stimulation-produced analgesia. ( Akil, H; Liebeskind, JC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (42.70) | 18.7374 |
| 1990's | 10 (11.24) | 18.2507 |
| 2000's | 18 (20.22) | 29.6817 |
| 2010's | 17 (19.10) | 24.3611 |
| 2020's | 6 (6.74) | 2.80 |
| Authors | Studies |
|---|---|
| Oberdorf, C | 1 |
| Schepmann, D | 1 |
| Vela, JM | 3 |
| Diaz, JL | 2 |
| Holenz, J | 1 |
| Wünsch, B | 1 |
| Liu, H | 1 |
| Altenbach, RJ | 1 |
| Carr, TL | 1 |
| Chandran, P | 1 |
| Hsieh, GC | 1 |
| Lewis, LG | 1 |
| Manelli, AM | 1 |
| Milicic, I | 1 |
| Marsh, KC | 1 |
| Miller, TR | 1 |
| Strakhova, MI | 1 |
| Vortherms, TA | 1 |
| Wakefield, BD | 1 |
| Wetter, JM | 1 |
| Witte, DG | 1 |
| Honore, P | 1 |
| Esbenshade, TA | 1 |
| Brioni, JD | 1 |
| Cowart, MD | 1 |
| Vivier, D | 1 |
| Bennis, K | 1 |
| Lesage, F | 1 |
| Ducki, S | 1 |
| García, M | 2 |
| Virgili, M | 1 |
| Alonso, M | 1 |
| Alegret, C | 1 |
| Fernández, B | 1 |
| Port, A | 2 |
| Pascual, R | 1 |
| Monroy, X | 1 |
| Vidal-Torres, A | 2 |
| Serafini, MT | 1 |
| Almansa, C | 2 |
| Torrens, A | 1 |
| Caamaño, AM | 1 |
| Enjo, J | 1 |
| Sicre, C | 1 |
| Lorente, A | 1 |
| Montero, A | 1 |
| Yeste, S | 1 |
| Álvarez, I | 1 |
| Martín, M | 1 |
| Maldonado, R | 1 |
| de la Puente, B | 1 |
| Cendán, CM | 3 |
| Dichiara, M | 1 |
| Artacho-Cordón, A | 1 |
| Turnaturi, R | 1 |
| Santos-Caballero, M | 1 |
| González-Cano, R | 1 |
| Pasquinucci, L | 1 |
| Barbaraci, C | 1 |
| Rodríguez-Gómez, I | 1 |
| Gómez-Guzmán, M | 1 |
| Marrazzo, A | 1 |
| Cobos, EJ | 3 |
| Amata, E | 1 |
| Minami, T | 1 |
| Watanabe, H | 1 |
| Kato, T | 1 |
| Ikeda, K | 1 |
| Ueno, K | 1 |
| Matsuyama, A | 1 |
| Maeda, J | 1 |
| Sakai, Y | 1 |
| Harada, H | 1 |
| Kuriyama, A | 1 |
| Yamaji, K | 1 |
| Kitajima, N | 1 |
| Kamei, J | 1 |
| Takatani, Y | 1 |
| Sato, Y | 1 |
| Yamashita, Y | 1 |
| Mizota, T | 1 |
| Ohtsuru, S | 1 |
| Wang, J | 1 |
| Peng, ZY | 1 |
| Zhou, WH | 1 |
| Hu, B | 1 |
| Rao, X | 1 |
| Li, JG | 1 |
| Ingravallo, F | 1 |
| de Nooijer, K | 1 |
| Pucci, V | 1 |
| Casini, C | 1 |
| Miccinesi, G | 1 |
| Rietjens, JAC | 1 |
| Morino, P | 1 |
| Wrobel, N | 1 |
| Wiech, K | 1 |
| Forkmann, K | 1 |
| Ritter, C | 1 |
| Bingel, U | 1 |
| Leppert, W | 2 |
| Okulicz-Kozaryn, I | 2 |
| Kaminska, E | 2 |
| Szulc, M | 1 |
| Mikolajczak, P | 2 |
| Salpeter, SR | 1 |
| Buckley, JS | 1 |
| Buckley, NS | 1 |
| Bruera, E | 1 |
| Azoulay, D | 1 |
| Shahal-Gassner, R | 1 |
| Yehezkel, M | 1 |
| Eliyahu, E | 1 |
| Weigert, N | 1 |
| Ein-Mor, E | 1 |
| Jacobs, JM | 1 |
| Baeyens, JM | 3 |
| Lee, IS | 1 |
| Lee, B | 1 |
| Park, HJ | 1 |
| Olausson, H | 1 |
| Enck, P | 1 |
| Chae, Y | 1 |
| Afzalimoghaddam, M | 1 |
| Edalatifard, M | 1 |
| Nejati, A | 1 |
| Momeni, M | 1 |
| Isavi, N | 1 |
| Karimialavijeh, E | 1 |
| Becker, A | 1 |
| Grecksch, G | 1 |
| Zernig, G | 1 |
| Ladstaetter, E | 1 |
| Hiemke, C | 1 |
| Schmitt, U | 1 |
| Melo, LL | 1 |
| Pereira, EC | 1 |
| Pagini, CH | 1 |
| Coimbra, NC | 1 |
| Brandão, ML | 1 |
| Ferrari, EA | 1 |
| Faaij, RA | 1 |
| Ziere, G | 1 |
| Zietse, R | 1 |
| Van der Cammen, TJ | 1 |
| Entrena, JM | 1 |
| Nieto, FR | 1 |
| Del Pozo, E | 1 |
| Stevenson, GW | 3 |
| Cormier, J | 1 |
| Mercer, H | 1 |
| Adams, C | 1 |
| Dunbar, C | 1 |
| Negus, SS | 3 |
| Bilsky, EJ | 3 |
| Do Carmo, GP | 1 |
| Petronilho, A | 1 |
| Reis, GM | 1 |
| Dias, QM | 1 |
| Fais, RS | 1 |
| Prado, WA | 2 |
| Morucci, F | 1 |
| Lopez, P | 1 |
| Miño, J | 1 |
| Ferraro, G | 1 |
| Gorzalczany, S | 1 |
| Kehl, LJ | 1 |
| Hamamoto, DT | 1 |
| Wacnik, PW | 1 |
| Croft, DL | 1 |
| Norsted, BD | 1 |
| Wilcox, GL | 1 |
| Simone, DA | 1 |
| BOISSIER, JR | 1 |
| PAGNY, J | 1 |
| GULLESTAD, S | 1 |
| Strakowski, SM | 1 |
| Johnson, JL | 1 |
| Delbello, MP | 1 |
| Hamer, RM | 1 |
| Green, AI | 1 |
| Tohen, M | 1 |
| Lieberman, JA | 1 |
| Glick, I | 1 |
| Patel, JK | 1 |
| Suaudeau, C | 1 |
| do-Rego, JC | 1 |
| Costentin, J | 1 |
| Pujalte, JM | 1 |
| Portillo-Salido, E | 1 |
| Negro, S | 1 |
| Martín, A | 1 |
| Azuara, ML | 1 |
| Sánchez, Y | 1 |
| Barcia, E | 1 |
| Ardenghi, JV | 1 |
| Kanegusuku, M | 1 |
| Niero, R | 1 |
| Filho, VC | 1 |
| Monache, FD | 1 |
| Yunes, RA | 1 |
| De Souza, MM | 1 |
| Grover, M | 1 |
| Edwards, F | 1 |
| Hitchcock, K | 1 |
| Stevens, MM | 1 |
| Yehuda, S | 1 |
| Youdim, MB | 1 |
| Snow, AE | 1 |
| Tucker, SM | 1 |
| Dewey, WL | 1 |
| Bodnar, RJ | 1 |
| Nicotera, N | 1 |
| Kharkevich, DA | 1 |
| Titov, MI | 1 |
| Hanks, GW | 1 |
| Thomas, PJ | 1 |
| Trueman, T | 1 |
| Weeks, E | 1 |
| Larson, AA | 2 |
| Kondzielski, MH | 1 |
| Fishbain, DA | 1 |
| Daw, JL | 1 |
| Cohen-Cole, SA | 1 |
| Lin, MT | 1 |
| Wu, JJ | 1 |
| Chandra, A | 1 |
| Tsay, BL | 1 |
| Cole, RM | 1 |
| Robinson, F | 1 |
| Harvey, L | 1 |
| Trethowan, K | 1 |
| Murdoch, V | 1 |
| Sun, X | 1 |
| Franco, AC | 1 |
| Hurford, WE | 1 |
| Magnusson, JE | 1 |
| Fisher, K | 1 |
| Sieklucka-Dziuba, M | 1 |
| Dziuba, J | 1 |
| Patyra, H | 1 |
| Kleinrok, Z | 1 |
| Benítez del Rosario, MA | 1 |
| Montón, F | 1 |
| Salinas, A | 1 |
| Martín, JJ | 1 |
| Feria, M | 1 |
| Kääriäinen, I | 1 |
| Ahtee, L | 1 |
| Chan, SH | 1 |
| Kocher, R | 3 |
| Akil, H | 1 |
| Liebeskind, JC | 1 |
| Head, M | 1 |
| Lal, H | 1 |
| Puri, S | 1 |
| Mantione, C | 1 |
| Valentino, D | 1 |
| Raft, D | 1 |
| Toomey, T | 1 |
| Gregg, JM | 1 |
| Berger, SH | 1 |
| Kraft, U | 1 |
| Kraft, H | 1 |
| Andreas, K | 1 |
| Tulunay, FC | 1 |
| Sparber, SB | 1 |
| Takemori, AE | 1 |
| Krowicki, ZK | 1 |
| Ventafridda, V | 1 |
| Ripamonti, C | 1 |
| Caraceni, A | 1 |
| Spoldi, E | 1 |
| Messina, L | 1 |
| De Conno, F | 1 |
| Antelman, SM | 1 |
| Caggiula, AR | 1 |
| Kocan, D | 1 |
| Knopf, S | 1 |
| Meyer, D | 1 |
| Edwards, DJ | 1 |
| Barry, H | 1 |
| Gastmeier, K | 1 |
| Hass, M | 1 |
| Schott, H | 1 |
| Kuteifan, K | 1 |
| Shannon, HE | 1 |
| Bemis, KG | 1 |
| Peters, SC | 1 |
| Kiyatkin, EA | 1 |
| Romo, R | 1 |
| Schultz, W | 1 |
| Hough, LB | 1 |
| Glick, SD | 1 |
| Su, K | 1 |
| Trubachev, VV | 1 |
| Solov'eva, NE | 1 |
| Bragin, EO | 1 |
| Venning, M | 1 |
| Rogers, J | 1 |
| Amir, S | 1 |
| Barasi, S | 1 |
| Ben-Sreti, MM | 1 |
| Clatworthy, AL | 1 |
| Duggal, KN | 1 |
| Gonzalez, JP | 1 |
| Robertson, J | 1 |
| Rooney, KF | 1 |
| Sewell, RD | 1 |
| Dykstra, LA | 1 |
| Woods, JH | 1 |
| Valenstein, M | 1 |
| Maltbie, A | 1 |
| Kaplan, P | 1 |
| Almazov, BN | 1 |
| Flügel, KA | 1 |
| Honma, T | 1 |
| Sasajima, K | 1 |
| Ono, K | 1 |
| Kitagawa, S | 1 |
| Inaba, S | 1 |
| Yamamoto, H | 1 |
| Rohrer, G | 1 |
| Burov, IuV | 1 |
| Speranskaia, NP | 1 |
| Gerardi, AU | 2 |
| Cardini, L | 2 |
| Tan, HSG | 1 |
| Lim, KC | 1 |
| Lui, JN | 1 |
| Lai, WMC | 1 |
| Yu, VSH | 1 |
| Drumond, JPSC | 1 |
| Maeda, W | 1 |
| Nascimento, WM | 1 |
| Campos, DL | 1 |
| Prado, MC | 1 |
| de-Jesus-Soares, A | 1 |
| Frozoni, M | 1 |
| Atav Ates, A | 1 |
| Dumani, A | 1 |
| Yoldas, O | 1 |
| Unal, I | 1 |
| Wong, AW | 1 |
| Zhang, S | 1 |
| Li, SK | 1 |
| Zhu, X | 1 |
| Zhang, C | 1 |
| Chu, CH | 1 |
| Asgary, S | 1 |
| Eghbal, MJ | 1 |
| De Moor, RJ | 1 |
| De Witte, AM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Survey of Management of Analgesia, Sedation and Delirium in ICU Patients in China[NCT04217915] | 800 participants (Anticipated) | Observational | 2021-07-12 | Recruiting | |||
| Pain Evaluation After Single Visit Nonsurgical Retreatment Using a Bio Ceramic Sealer[NCT05399303] | 100 participants (Actual) | Interventional | 2022-01-01 | Completed | |||
| Effect of Two Different Calcium Silicate Based and One Epoxy Resin-based Root Canal Sealers on Postoperative Pain After Root Canal Treatments[NCT03919318] | 90 participants (Actual) | Interventional | 2018-04-01 | Completed | |||
| Single Visit Root Canal Treatment :Incidence of Postoperative Pain Using Two Different Sealers : A Randomized Clinical Trial[NCT04482101] | 68 participants (Anticipated) | Interventional | 2020-09-01 | Not yet recruiting | |||
| The Effect of Two Different Root Canal Sealers on Postobturation Pain in Single-Visit Root Canal Treatment: A Prospective Clinical Randomized Study- Part 1, Influence of Resin-based and Mineral Trioxide Aggregate-based Sealers on Treatment Outcome After T[NCT05266599] | 100 participants (Actual) | Interventional | 2019-11-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for haloperidol and Ache
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Struc | 2016 |
[Peptides with analgesic activity].
Topics: Analgesics, Opioid; Animals; Cats; Drug Interactions; Endorphins; Enkephalins; Haloperidol; Mice; Ne | 1982 |
Opioid and catecholaminergic mechanisms of different types of analgesia.
Topics: Acetates; Acetic Acid; Acupuncture Therapy; Analgesia; Animals; Electric Stimulation; Electroshock; | 1986 |
Catalepsy induced by body pinch: relation to stress-induced analgesia.
Topics: Analgesia; Animals; Apomorphine; Catalepsy; Endorphins; Haloperidol; Mice; Naloxone; Pain; Receptors | 1986 |
8 trials available for haloperidol and Ache
| Article | Year |
|---|---|
Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial).
Topics: Critical Illness; Delirium; Dexmedetomidine; Drugs, Investigational; Haloperidol; Humans; Hypnotics | 2023 |
Midazolam Plus Haloperidol as Adjuvant Analgesics to Morphine in Opium Dependent Patients: A Randomized Clinical Trial.
Topics: Adult; Analgesics; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Drug T | 2016 |
Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Disease Progression; Double-Blind Method; Female; Foll | 2005 |
[Treatment of severe chronic pains with a combination of thymoleptics and neuroleptics (author's transl)].
Topics: Adult; Antidepressive Agents; Atropine; Chlorpromazine; Clinical Trials as Topic; Clomipramine; Drug | 1974 |
Postobturation Pain Associated with Tricalcium Silicate and Resin-based Sealer Techniques: A Randomized Clinical Trial.
Topics: Calcium Compounds; Epoxy Resins; Humans; Materials Testing; Pain; Root Canal Filling Materials; Root | 2021 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Post-obturation pain following the use of carrier-based system with AH Plus or iRoot SP sealers: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Epoxy Resins; Female; Humans; Male; Middle Aged; Pain; Prospective Studies; Root | 2019 |
Incidence of post-obturation pain after single-visit versus multiple-visit non-surgical endodontic treatments.
Topics: Adult; Appointments and Schedules; Calcium Hydroxide; Dental Fistula; Epoxy Resins; Female; Follow-U | 2015 |
A clinical trial of pulpotomy vs. root canal therapy of mature molars.
Topics: Adolescent; Adult; Aged; Analgesics; Calcium Compounds; Calcium Sulfate; Child; Dental Cements; Epox | 2010 |
77 other studies available for haloperidol and Ache
| Article | Year |
|---|---|
Thiophene bioisosteres of spirocyclic sigma receptor ligands. 1. N-substituted spiro[piperidine-4,4'-thieno[3,2-c]pyrans].
Topics: Alkylation; Animals; Cyclization; Ligands; Mice; Models, Molecular; Molecular Structure; Oxidation-R | 2008 |
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; | 2008 |
4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ
Topics: Alkanes; Analgesics; Analgesics, Opioid; Animals; Humans; Male; Mice; Models, Molecular; Pain; Pain | 2020 |
EST64454: a Highly Soluble σ
Topics: Analgesics; Animals; Caco-2 Cells; Humans; Mice; Molecular Structure; Pain; Piperazines; Pyrazoles; | 2020 |
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.
Topics: Animals; Guinea Pigs; Hydrogen; Hydrogen Sulfide; Ligands; Male; Morpholines; Pain; Piperazines; Rat | 2022 |
A National Multicenter Survey on Management of Pain, Agitation, and Delirium in Intensive Care Units in China.
Topics: Delirium; Dexmedetomidine; Fentanyl; Haloperidol; Humans; Hypnotics and Sedatives; Intensive Care Un | 2017 |
Discussions about palliative sedation in hospice: Frequency, timing and factors associated with patient involvement.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antipsychotic Agents; Decision Making, Shared; Delirium | 2019 |
Haloperidol blocks dorsal striatum activity but not analgesia in a placebo paradigm.
Topics: Adolescent; Adult; Analgesia; Brain; Brain Mapping; Dopamine Antagonists; Female; Haloperidol; Human | 2014 |
Analgesic effects of morphine in combination with adjuvant drugs in rats.
Topics: Adjuvants, Pharmaceutic; Analgesics, Opioid; Animals; Butylscopolammonium Bromide; Drug Interactions | 2014 |
The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report.
Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; California; Dose-Response Relatio | 2015 |
Palliative Sedation at the End of Life: Patterns of Use in an Israeli Hospice.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antipsychotic Agents; Female; Haloperidol; Hospices; Hu | 2016 |
Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in Palliative Care Patients: Are the Sigma-1 Receptors Involved?
Topics: Analgesics, Opioid; Female; Haloperidol; Humans; Male; Methadone; Morphine; Pain; Pain Management; P | 2015 |
A new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning.
Topics: Analgesia; Animals; Dopamine Antagonists; Gyrus Cinguli; Haloperidol; Immunohistochemistry; Male; Mo | 2015 |
Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.
Topics: Analgesics, Opioid; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Electric Stimul | 2009 |
Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
Topics: Acoustic Stimulation; Animals; Apomorphine; Avoidance Learning; Conditioning, Classical; Dopamine; D | 2009 |
Delirium due to a drug-drug interaction of lithium and an NSAID.
Topics: Accidental Falls; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antidepressi | 2009 |
Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.
Topics: Analysis of Variance; Animals; Brain; Capsaicin; Disease Models, Animal; Dopamine Antagonists; Dose- | 2009 |
Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.
Topics: Acetic Acid; Analgesia; Analgesics; Animals; Behavior, Animal; Benzene Derivatives; Caffeine; Diseas | 2009 |
Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia.
Topics: Acetic Acid; Analgesia; Analgesics; Animals; Behavior, Animal; Drug Evaluation, Preclinical; Haloper | 2010 |
Antinociceptive effect of stimulating the zona incerta with glutamate in rats.
Topics: Analgesics; Animals; Atropine; Glutamic Acid; Haloperidol; Male; Mecamylamine; Methysergide; Microin | 2012 |
Antinociceptive activity of aqueous extract and isolated compounds of Lithrea molleoides.
Topics: Acetic Acid; Adrenergic alpha-2 Receptor Antagonists; Anacardiaceae; Analgesics; Animals; Behavior, | 2012 |
Analgesic effects of tramadol in combination with adjuvant drugs: an experimental study in rats.
Topics: Adjuvants, Pharmaceutic; Analgesia; Analgesics; Animals; Anti-Anxiety Agents; Antiemetics; Antipsych | 2013 |
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain.
Topics: Animals; Benzoxazines; Calcium Channel Blockers; Camphanes; Cannabinoids; Carrageenan; Catalepsy; Di | 2003 |
[Pharmacodynamic study of a new important neuroleptic: haloperidol (R-1625). I. Toxicity. Its potentiator action in anesthesia and analgesia].
Topics: Analgesia; Anesthesia; Antipsychotic Agents; Haloperidol; Humans; Hypnotics and Sedatives; Pain; Pai | 1960 |
[Neuroleptal analgesia].
Topics: Analgesia; Haloperidol; Pain; Pain Management; Tranquilizing Agents | 1963 |
Modifications in avoidance reactions of mice, on a second exposure to the hot plate, resist to various amnesia-inducing treatments.
Topics: Analysis of Variance; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Dementia; Diaz | 2005 |
Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice.
Topics: Analgesics; Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug | 2005 |
Stability of tramadol and haloperidol for continuous subcutaneous infusion at home.
Topics: Analgesics, Opioid; Antipsychotic Agents; Chemical Phenomena; Chemistry, Physical; Drug Combinations | 2005 |
Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice.
Topics: Acetic Acid; Analgesics, Opioid; Animals; Behavior, Animal; Disease Models, Animal; Dopamine Antagon | 2006 |
Analysis of the mechanism of antinociceptive action of niga-ichigoside F1 obtained from Rubus imperialis (Rosaceae).
Topics: Analgesics; Animals; Apomorphine; Atropine; Capsaicin; Dose-Response Relationship, Drug; Drug Admini | 2006 |
Clinical inquiries. What steps can reduce morbidity and mortality caused by hip fractures?
Topics: Aged; Analgesics; Antibiotic Prophylaxis; Antipsychotic Agents; Bacterial Infections; Cephalosporins | 2007 |
The increased opiate action of beta-endorphin in iron-deficient rats: the possible involvement of dopamine.
Topics: Animals; beta-Endorphin; Blood-Brain Barrier; Circadian Rhythm; Dopamine; Endorphins; Haloperidol; I | 1984 |
The role of neurotransmitters in stress-induced antinociception (SIA).
Topics: Animals; Apomorphine; Clonidine; Dopamine; Haloperidol; Kinetics; Male; Neurotransmitter Agents; Nor | 1982 |
Neuroleptic and analgesic interactions upon pain and activity measures.
Topics: Analgesics; Animals; Antipsychotic Agents; Chlordiazepoxide; Chlorpromazine; Deoxyglucose; Drug Inte | 1982 |
The myth of haloperidol potentiation.
Topics: Antiemetics; Drug Synergism; Haloperidol; Humans; Morphine; Pain | 1983 |
Serotonin-induced gnawing in rats: comparison with tail pinch-induced gnawing.
Topics: Animals; Dopamine; Haloperidol; Humans; Injections, Intraperitoneal; Injections, Spinal; Methysergid | 1982 |
Pain insensitivity in psychosis.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Diagnosis, Differential; Duodenal Ulcer; Female; Haloperido | 1982 |
Haloperidol analgesia.
Topics: Adult; Haloperidol; Humans; Pain; Radiotherapy | 1981 |
Activation of striatal dopamine receptors induces pain inhibition in rats.
Topics: Animals; Apomorphine; Caudate Nucleus; Cerebral Ventricles; Corpus Striatum; Electric Stimulation; H | 1981 |
Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer.
Topics: Analgesics; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Haloperidol; Humans | 1994 |
The amino-terminus of substance P mimics and MK-801 attenuates the effects of capsaicin on nociception and kainic acid-induced behavior in the mouse.
Topics: Analysis of Variance; Animals; Capsaicin; Dizocilpine Maleate; Haloperidol; Kainic Acid; Male; Mice; | 1993 |
Antinociceptive effects of stimulation of discrete sites in the rat hypothalamus: evidence for the participation of the lateral hypothalamus area in descending pain suppression mechanisms.
Topics: Adrenergic alpha-Antagonists; Analgesia; Analgesics, Opioid; Animals; Atropine; Dopamine Antagonists | 1996 |
Sedation in the intensive care unit.
Topics: Analgesics, Opioid; Anesthetics, General; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Benzod | 1999 |
The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Dopamine; Dopa | 2000 |
Central action of some cytostatics--methotrexate (MTX) and doxorubicin (DXR). I. Long-term influence on the pain sensitivity and activity of brain dopaminergic system in mice.
Topics: Analgesics; Animals; Behavior, Animal; Body Weight; Brain; Catalepsy; Doxorubicin; Drug Interactions | 1998 |
Charles Bonnet syndrome and opioids.
Topics: Aged; Analgesics, Opioid; Antipsychotic Agents; Blindness; Diagnosis, Differential; Fatal Outcome; H | 2001 |
Effect of narcotic analgesics on the striatal homovanillic acid content in mice; relation to antinociceptive effect.
Topics: Analgesics, Opioid; Animals; Body Temperature; Corpus Striatum; Cyclazocine; Haloperidol; Homovanill | 1976 |
Central neurotransmitter systems in the morphine suppression of jaw-opening reflex in rabbits: the dopaminergic system.
Topics: Animals; Apomorphine; Dopamine; Dopamine Antagonists; Haloperidol; Jaw; Morphine; Neurotransmitter A | 1979 |
[The treatment of chronic pain symptoms with psychotropic drugs (author's transl)].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bone Diseases; Clomipramine; Drug Therapy, C | 1976 |
Monoaminergic mechanisms of stimulation-produced analgesia.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Apomorphine; Brain; Cerebral Aqueduct; Disulfiram; Dopamine | 1975 |
[The treatment of chronic pain with psychotropic drugs].
Topics: Clomipramine; Haloperidol; Humans; Imipramine; Methotrimeprazine; Muscle Contraction; Pain; Psychotr | 1978 |
Enhancement of morphine analgesia after acute and chronic haloperidol.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dose-Response Relationship, Drug; Drug Synergism; Halope | 1979 |
Behavior modification and haloperidol in chronic facial pain.
Topics: Chronic Disease; Face; Female; Haloperidol; Humans; Male; Middle Aged; MMPI; Pain; Pain Management; | 1979 |
Trifluoperazine and haloperidol: sources of ejaculatory pain?
Topics: Adult; Ejaculation; Haloperidol; Humans; Male; Molindone; Pain; Psychotic Disorders; Trifluoperazine | 1979 |
[Effect of dopaminergic substances on the antinocifensive action of arecoline].
Topics: Amphetamine; Animals; Apomorphine; Arecoline; Chlorpromazine; Dopamine; Dose-Response Relationship, | 1979 |
The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
Topics: Analgesics; Animals; Apomorphine; Depression, Chemical; Dopamine; Haloperidol; Levodopa; Male; Mice; | 1975 |
Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
Topics: Amino Acid Sequence; Animals; Benzazepines; Dopamine Antagonists; Drug Synergism; Foot; Haloperidol; | 1991 |
The management of inoperable gastrointestinal obstruction in terminal cancer patients.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Butylscopolammonium Bromide; Drug Administratio | 1990 |
One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Catalepsy; Corticosterone; Deoxygluco | 1991 |
[Pain therapy for urologic cancer patients at the Potsdam district hospital--initial results].
Topics: Aged; Amitriptyline; Analgesics; Analgesics, Opioid; Aspirin; Carbamazepine; Codeine; Dipyrone; Drug | 1990 |
Effects of oral pergolide mesylate on nociceptive spinal cord reflexes in rats.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Female; Haloperidol; Pain; Pergolide; Rats | 1991 |
Dopaminergic involvement in nociceptive sensitivity/behavioral reactivity regulation during aversive states of different nature in the rat.
Topics: Acetates; Acetic Acid; Animals; Apomorphine; Ascorbic Acid; Avoidance Learning; Behavior, Animal; Do | 1989 |
Somatosensory input to dopamine neurones of the monkey midbrain: responses to pain pinch under anaesthesia and to active touch in behavioural context.
Topics: Action Potentials; Anesthesia; Animals; Behavior, Animal; Dopamine; Electric Stimulation; Haloperido | 1989 |
A role for histamine and histamine H2-receptors in non-opiate footshock-induced analgesia.
Topics: Animals; Cimetidine; Electroshock; Haloperidol; Histamine; Histamine H2 Antagonists; Male; Naloxone; | 1985 |
[Dynamic changes in the heart beat frequency of rabbits to auditory and nociceptive signals against the background of neuroleptic action].
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Chlorpromazine; Conditioning, Classical; Electr | 1988 |
Continuous subcutaneous infusion: flexible option in symptom control.
Topics: Anxiety; Female; Haloperidol; Humans; Infusion Pumps; Infusions, Parenteral; Metoclopramide; Middle | 1988 |
Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Benz | 1987 |
A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Female; Haloperidol; Hot Temperature; Male; M | 1986 |
Catatonia in the emergency department.
Topics: Adult; Aged; Bipolar Disorder; Catatonia; Diagnosis, Differential; Emergency Service, Hospital; Halo | 1985 |
[Comparative results of pharmacologic loading with aminazine and heloperidol in the treatment of the simple form of schizophrenia (according to pain sensography findings)].
Topics: Adolescent; Adult; Chlorpromazine; Female; Haloperidol; Humans; Hypesthesia; Male; Pain; Schizophren | 1974 |
[Treatment of acute emotional disturbances].
Topics: Alcohol Withdrawal Delirium; Chlormethiazole; Chlorpromazine; Chlorprothixene; Diazepam; Family Char | 1974 |
Synthesis and preliminary pharmacology of a novel butyrophenone derivative, ID-4708.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Butyrophenones; Catalepsy; Cats; Chlorpr | 1974 |
[Effect of psychotropic agents on development of an avoidance reaction in albino rats during painful electric stimulation of another rat].
Topics: Amphetamine; Animals; Antidepressive Agents; Droperidol; Electric Stimulation; Escape Reaction; Fear | 1973 |
[Sensitivity to pain and pharmacological action. (Clinical and experimental studies of some pharmacological substances of common clinical use on sensitivity to pain stimuli)].
Topics: Animals; Benperidol; Fentanyl; Haloperidol; Neuroleptanalgesia; Pain; Rats; Sensation | 1968 |
[Sensitivity to pain and pharmacological action. (Clinical and experimental studies of some pharmacological substances of common clinical use of sensitivity to pain stimuli)].
Topics: Animals; Benperidol; Fentanyl; Haloperidol; Neuroleptanalgesia; Pain; Rats; Sensation | 1968 |
Comparison of Postobturation Pain Experience after Apical Extrusion of Calcium Silicate- and Resin-Based Root Canal Sealers.
Topics: Brazil; Calcium Compounds; Dental Pulp Cavity; Epoxy Resins; Humans; Materials Testing; Pain; Root C | 2021 |
Periapical lesions accidentally filled with calcium hydroxide.
Topics: Accidents; Adolescent; Adult; Bismuth; Calcium Hydroxide; Dental Fistula; Drug Combinations; Epoxy R | 2002 |